Dudediligence.

Regeneron Pharmaceuticals, Inc

REGNNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.72BSep ’24$3.79BDec ’24$3.03BMar ’25$3.68BJun ’25$3.75BSep ’25$3.88BDec ’25$3.61BMar ’26$4.29BJun ’26
Net income, by quarter
$1.34BSep ’24$917.7MDec ’24$808.7MMar ’25$1.39BJun ’25$1.46BSep ’25$844.6MDec ’25$727.2MMar ’26$1.30BJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$16.07B$12.17B$13.12B$14.20B$14.34B
Operating income$8.95B$4.74B$4.05B$3.99B$3.58B
Net income$8.08B$4.34B$3.95B$4.41B$4.50B
Operating cash flow$7.08B$5.01B$4.59B$4.42B$4.98B
Free cash flow$6.53B$4.42B$3.88B$3.66B$4.08B
Cash$2.89B$3.11B$2.73B$2.49B$3.12B
Debt$1.98B$1.98B$1.98B$1.98B$1.99B
Shares outstanding112.2M113.5M113.7M115.1M108.6M